IPHA
Price
$2.14
Change
-$0.00 (-0.00%)
Updated
Aug 6 closing price
Capitalization
197.93M
41 days until earnings call
TNXP
Price
$45.76
Change
-$1.94 (-4.07%)
Updated
Aug 6, 04:59 PM (EDT)
Capitalization
335.64M
4 days until earnings call
Interact to see
Advertisement

IPHA vs TNXP

Header iconIPHA vs TNXP Comparison
Open Charts IPHA vs TNXPBanner chart's image
Innate Pharma SA
Price$2.14
Change-$0.00 (-0.00%)
Volume$4.12K
Capitalization197.93M
Tonix Pharmaceuticals Holding
Price$45.76
Change-$1.94 (-4.07%)
Volume$3.84K
Capitalization335.64M
IPHA vs TNXP Comparison Chart in %
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. TNXP commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a StrongBuy and TNXP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (IPHA: $2.14 vs. TNXP: $45.62)
Brand notoriety: IPHA and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 41% vs. TNXP: 114%
Market capitalization -- IPHA: $197.93M vs. TNXP: $335.64M
IPHA [@Biotechnology] is valued at $197.93M. TNXP’s [@Biotechnology] market capitalization is $335.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 0 FA rating(s) are green whileTNXP’s FA Score has 2 green FA rating(s).

  • IPHA’s FA Score: 0 green, 5 red.
  • TNXP’s FA Score: 2 green, 3 red.
According to our system of comparison, TNXP is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 5 TA indicator(s) are bullish while TNXP’s TA Score has 5 bullish TA indicator(s).

  • IPHA’s TA Score: 5 bullish, 5 bearish.
  • TNXP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TNXP is a better buy in the short-term than IPHA.

Price Growth

IPHA (@Biotechnology) experienced а +1.66% price change this week, while TNXP (@Biotechnology) price change was +18.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.54%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +13.42%.

Reported Earning Dates

IPHA is expected to report earnings on Sep 17, 2025.

TNXP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-0.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNXP($336M) has a higher market cap than IPHA($198M). TNXP YTD gains are higher at: 38.326 vs. IPHA (16.576).
IPHATNXPIPHA / TNXP
Capitalization198M336M59%
EBITDAN/A-66.23M-
Gain YTD16.57638.32643%
P/E RatioN/A0.13-
RevenueN/A10M-
Total CashN/A132M-
Total DebtN/A563K-
FUNDAMENTALS RATINGS
TNXP: Fundamental Ratings
TNXP
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
24

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHATNXP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZLYF12.390.64
+5.41%
Beazley Plc
SEOVF0.14N/A
+2.20%
SERNOVA BIOTHERAPEUTICS INC.
MGDDY17.860.03
+0.17%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
SNBH0.06N/A
N/A
Sentient Brands Holdings Inc.
DTTLF3.56N/A
N/A
Datatec Ltd. S.A.

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+0.23%
MDGL - IPHA
43%
Loosely correlated
-0.24%
SLNO - IPHA
34%
Loosely correlated
-0.54%
VALN - IPHA
30%
Poorly correlated
+4.07%
TNXP - IPHA
30%
Poorly correlated
-4.36%
QSI - IPHA
28%
Poorly correlated
-4.86%
More